{"chunk_id": "tnm_chunk_0", "text": "INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724049", "page": 1, "cancer_type": "Unknown", "category": "Unknown", "cancer_site": null, "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 54}}
{"chunk_id": "tnm_chunk_1", "text": "Lung Cancer T Classi\ufb01 cation\u20139th Edition\n\nFigure. Courtesy of International Association for the Study of Lung Cancer. Permission must be requested and granted before\nphotocopying or reproducing this material for distribution. Copyright \u00a92024 Aletta Ann Frazier, MD.\nTumor > 4cm, \u2264 5cm\n(with or without other\nT2 descriptors)\nTumor involves main\nbronchus, regardless of\ndistance from carina but\nwithout carinal involvement\nTumor \u2264 4cm, invasion\nof the visceral pleura\nNote: if the tumor is associated with atelectasis or pneumonitis,\nit is T2a if lesion \u2264 4cm or if tumor size cannot be measured; it is\nT2b if lesion > 4cm, \u2264 5cm.\nT2a\nT2b\nTumor > 3cm, \u2264 4cm\nAssociated atelectasis or\nobstructive pneumonitis that\nextends to the hilar region,\neither involving part of the\nlung or the entire lung\nT1a:\nTumor \u22641cm\nT1b: Tumor\n>1cm, \u22642cm\nT1c: Tumor\n>2cm, \u22643cm\n\nTumor \u22643cm; without\nendobronchial extension proximal\nto the lobar bronchus\nT1a, T1b\nT1c\nSuperficial spreading tumor of any\nsize with its invasive component\nlimited to the bronchial wall, which\nmay extend proximal to the main\nbronchus, is T1\n\nINTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724073", "page": 1, "cancer_type": "Lung", "category": "Unknown", "cancer_site": "Lung Cancer T Classi\ufb01 cation\u20139th Edition", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 1150}}
{"chunk_id": "tnm_chunk_2", "text": "Lung Cancer T Classi\ufb01 cation\u20139th Edition\n\nTumor invades parietal pleura or\nchest wall or invades thoracic T1,\nT2 nerve roots, or stellate ganglion\nTumor > 5cm, \u2264 7cm\nSeparate tumor nodule(s) in\nthe lobe of the primary\nT3\nInvasion\nof parietal\npleura\nDiaphragmatic\ninvasion\nTumor involves\ncarina\nTumor invades trachea\nand/or SVC or other\ngreat vessel\nTumor > 7cm\nTumor invades\nadjacent\nvertebral body\nTumour invades mediastinum,\nthymus, heart, vagus nerve,\nrecurrent laryngeal nerve,\nesophagus or diaphragm\nT4\nTumor accompanied\nby ipsilateral, separate\ntumor nodules,\ndi\ufb00 erent lobe\nTumor that invades\nsubclavian vessels,\nvertebral body,\nlamina, spinal canal,\ncervical nerve roots,\nor brachial plexus\nVan Schil PE, Asamura H, Nishimura KK, et al. The IASLC lung cancer staging project: Proposals for the revisions of the T\ndescriptors in the forthcoming ninth edition of the TNM classification for lung cancer. J Thorac Oncol. 2024; 19(5):749-765.\nInvasion of the\nazygos vein,\nphrenic nerve, or\npericardium\n\nINTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724078", "page": 2, "cancer_type": "Lung", "category": "Unknown", "cancer_site": "Lung Cancer T Classi\ufb01 cation\u20139th Edition", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 1060}}
{"chunk_id": "tnm_chunk_3", "text": "Lung Cancer N Classi\ufb01 cation\u20139th Edition\n\nFigure. Courtesy of International Association for the Study of Lung Cancer. Permission must be requested and granted before\nphotocopying or reproducing this material for distribution. Copyright \u00a92024 Aletta Ann Frazier, MD.\nNo regional\nlymph node\nmetastases\nMetastasis\nin ipsilateral\nintrapulmonary/\nperibronchial/\nhilar lymph node(s),\nincluding nodal\ninvolvement by\ndirect extension\nN0\nN1\n\nINTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724082", "page": 3, "cancer_type": "Lung", "category": "Unknown", "cancer_site": "Lung Cancer N Classi\ufb01 cation\u20139th Edition", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 487}}
{"chunk_id": "tnm_chunk_4", "text": "Lung Cancer N Classi\ufb01 cation\u20139th Edition\n\nHuang J, Osarogiagbon RU, Giroux DJ, et al. The International Association for the Study of Lung Cancer staging project for lung\ncancer: Proposals for the revision of the N descriptors in the forthcoming ninth edition of the TNM classification for lung cancer.\nJ Thorac Oncol. 2024; 19(5):766-785.\nMetastasis to\nsingle ipsilateral\nmediastinal or\nsubcarinal lymph\nnode station\nN2a\nMetastasis to\nmultiple ipsilateral\nmediastinal and/or\nsubcarinal lymph\nnode stations\nN2b\n\nINTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724086", "page": 4, "cancer_type": "Lung", "category": "Unknown", "cancer_site": "Lung Cancer N Classi\ufb01 cation\u20139th Edition", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 565}}
{"chunk_id": "tnm_chunk_5", "text": "Lung Cancer N, M Classi\ufb01 cation\u20139th Edition\n\nFigure. Courtesy of International Association for the Study of Lung Cancer. Permission must be requested and granted before\nphotocopying or reproducing this material for distribution. Copyright \u00a92024 Aletta Ann Frazier, MD.\nMetastasis in\ncontralateral hilar/\nmediastinal/scalene/\nsupraclavicular\nlymph node(s)\nMetastasis in\nipsilateral scalene/\nsupraclavicular\nlymph node(s)\nN3\nContralateral,\nseparate\ntumor nodule(s)\nNote: when the pleural (pericardial) e\ufb00 usions are negative af er multiple microscopic examinations, and\nthe fluid is non-bloody and not an exudate, they should be excluded as a staging descriptor.\nMalignant pericardial e\ufb00 usion/nodule(s)\nMalignant\npleural e\ufb00 usion/\nnodule(s)\nM1a\nPrimary\ntumor\n\nINTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724090", "page": 5, "cancer_type": "Lung", "category": "Unknown", "cancer_site": "Lung Cancer N, M Classi\ufb01 cation\u20139th Edition", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 813}}
{"chunk_id": "tnm_chunk_6", "text": "Lung Cancer M Classi\ufb01 cation\u20139th Edition\n\nLiver\nM1b\nSingle extrathoracic\nmetastasis\nM1b\nThis includes\ninvolvement of\na single distant\n(non-regional)\nlymph node\nFong KM, Rosenthal A, Giroux DJ, et al. The International\nAssociation for the Study of Lung Cancer staging project for\nlung cancer: Proposals for the revision of the M descriptors\nin the forthcoming ninth edition of the TNM classification of\nlung cancer. J Thorac Oncol. 2024; 19(5):786-802.\n\nINTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724094", "page": 6, "cancer_type": "Lung", "category": "Unknown", "cancer_site": "Lung Cancer M Classi\ufb01 cation\u20139th Edition", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 507}}
{"chunk_id": "tnm_chunk_7", "text": "Lung Cancer M Classi\ufb01 cation\u20139th Edition\n\nFigure. Courtesy of International Association for the Study of Lung Cancer. Permission must be requested and granted before\nphotocopying or reproducing this material for distribution. Copyright \u00a92024 Aletta Ann Frazier, MD.\nFong KM, Rosenthal A, Giroux DJ, et al. The International Association for the Study of Lung Cancer staging project for lung\ncancer: Proposals for the revision of the M descriptors in the forthcoming ninth edition of the TNM classification of lung cancer.\nJ Thorac Oncol. 2024; 19(5):786-802.\nM1c2\nM1c1\nMultiple\nliver\nmetastases\nLiver\nBrain\nLymph\nnodes\nBone\nAdrenal\nMultiple\nextrathoracic\nmetastases\nin multiple\norgan systems\nMultiple\nextrathoracic\nmetastases in\na single organ\nsystem\nAn organ system denotes\nall sites of an organ that is\ndistributed in the body (e.g.\nthe skeletal system, skin,\nextrathoracic lymphatic\nsystem) or of a paired organ\n(e.g. adrenal, kidney)", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724098", "page": 7, "cancer_type": "Lung", "category": "Unknown", "cancer_site": "Lung Cancer M Classi\ufb01 cation\u20139th Edition", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 938}}
{"chunk_id": "tnm_chunk_8", "text": "Lung Cancer M Classi\ufb01 cation\u20139th Edition\n\nINTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER\nLung TNM De\ufb01 nitions\u20139th Edition\nT: Primary tumor\nTx\nPrimary tumor cannot be assesseda\nT0\nNo evidence of primary tumor\nTis\nCarcinoma in situb\nT1\nTumor surrounded by lung or visceral pleura, or in a\nlobar or more peripheral bronchusc\nT1mi\nMinimally invasive adenocarcinomad\nT1a\nTumor \u22641 cm in greatest dimension\nT1b\nTumor >1 cm but \u22642 cm in greatest dimension\nT1c\nTumor >2 cm but \u22643 cm in greatest dimension\nT2\nTumor with any of the following features:\nT2a\n\u2022 tumor >3 cm but \u22644 cm in greatest dimension;\n\u2022 invades visceral pleura;\n\u2022 invades an adjacent lobe;\n\u2022 involves main bronchus (up to but not including the\ncarina) or is associated with atelectasis or obstruc-\ntive pneumonitis extending to the hilar region,\ninvolving either part of or the entire lung\nT2b\nTumor >4 cm but \u22645 cm in greatest dimension\nT3\nTumor with any of the following features:\n\u2022 tumor >5 cm but \u22647 cm in greatest dimension;\n\u2022 invades parietal pleura or chest wall;\n\u2022 invades pericardium, phrenic nerve, or azygos vein;e\n\u2022 invades thoracic nerve roots (i.e. T1, T2) or stellate\nganglion;\n\u2022 separate tumor nodule(s) in the same lobe as the\nprimary\nT4\nTumor with any of the following features:\n\u2022 tumor >7 cm in greatest dimension;\n\u2022 invades mediastinum, thymus, trachea, carina,\nrecurrent laryngeal nerve, vagus nerve, esophagus\nor diaphragm;\n\u2022 invades heart, great vessels (aorta, superior/inferior\nvena cava, intrapericardial pulmonary arteries/\nveins), supra-aortic arteries, or brachiocephalic\nveins;\n\u2022 invades subclavian vessels, vertebral body, lamina,\nspinal canal, cervical nerve roots, or brachial plexus\n(i.e. trunks, divisions, cords, or terminal nerves);\n\u2022 separate tumor nodule(s) in a di\ufb00 erent ipsilateral\nlobe than that of the primary\na This includes tumors proven by the presence of malignant cells\nin sputum or bronchial washings but not visualized by imaging or\nbronchoscopy.\nb This includes adenocarcinoma in situ \u2013 Tis (AIS) \u2013 and squamous\ncell carcinoma in situ \u2013 Tis (SCIS).\nc The uncommon super\ufb01 cial spreading tumor of any size with its\ninvasive component limited to the bronchial wall, which may extend\nproximal to the main bronchus, is also classi\ufb01 ed as T1a.\nd Solitary adenocarcinoma (not more than 3 cm in greatest dimen-\nsion), with a predominantly lepidic pattern and not more than 5 mm\ninvasion in greatest dimension.\ne Although these structures lie within the mediastinum, the degree\nof mediastinal penetration by the tumor needed to invade these\nstructures is not counted as T4.\nN: Regional Lymph Nodes\nNX\nRegional lymph nodes cannot be assessed\nN0\nNo regional lymph node metastasis\nN1\nMetastasis in ipsilateral peribronchial and/or ipsilateral\nhilar and/or intrapulmonary lymph nodes, including\ninvolvement by direct extension\nN2\nMetastasis in ipsilateral mediastinal and/or subcarinal\nlymph node(s)\nN2a \u2013 Single N2 station involvement\nN2b \u2013 Multiple N2 station involvement\nN3\nMetastasis in contralateral mediastinal, contralateral\nhilar, ipsilateral or contralateral scalene or supraclavicular\nlymph node(s)\nM: Distant Metastasis\nM0\nNo distant metastasis\nM1\nDistant metastasis\nM1a\nTumor with pleural or pericardial nodules or malignant\npleural or pericardial e\ufb00 usions, separate tumor nodule(s)\nin a contralateral lobe\nM1b\nSingle extrathoracic metastasis in a single organ system\nM1c\nMultiple extrathoracic metastases\nM1c1\nMultiple extrathoracic metastases in a single organ\nsystem\nM1c2\nMultiple extrathoracic metastases in multiple organ\nsystems", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724101", "page": 7, "cancer_type": "Lung", "category": "Unknown", "cancer_site": "Lung Cancer M Classi\ufb01 cation\u20139th Edition", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 3553}}
{"chunk_id": "tnm_chunk_9", "text": "Lung Cancer M Classi\ufb01 cation\u20139th Edition\n\nINTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER\nNodal Chart\u20139th Edition", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724105", "page": 7, "cancer_type": "Lung", "category": "Unknown", "cancer_site": "Lung Cancer M Classi\ufb01 cation\u20139th Edition", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 122}}
{"chunk_id": "tnm_chunk_10", "text": "N1 NODES\n\n1 Low cervical, supraclavicular,\nand sternal notch nodes\n2R Upper Paratracheal (right)\n2L Upper Paratracheal (lef )\n3a  Prevascular\n3p Retrotracheal\n4R Lower Paratracheal (right)\n4L Lower Paratracheal (lef )\n5 Subaortic\n6 Para-aortic (ascending aorta or phrenic)\n7 Subcarinal\n8 Paraesophageal (below carina)\n9 Pulmonary ligament\n10 Hilar\n11 Interlobar\n12 Lobar\n13 Segmental\n14 Subsegmental\nSupraclavicular zone\nUpper zone\nAP zone\nSubcarinal zone\nLower zone\nHilar/Interlobar zone\nPeripheral zone", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724109", "page": 9, "cancer_type": "Unknown", "category": "Unknown", "cancer_site": "N1 NODES", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 506}}
{"chunk_id": "tnm_chunk_11", "text": "N1 NODES\n\nINTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER\nIASLC Nodal De\ufb01 nitions\u20139th Edition\n#1 (Left/Right) Low cervical, supraclavicular and\nsternal notch nodes\nUpper border: Lower margin of cricoid cartilage\nLower border: Clavicles bilaterally and, in the midline, the upper\nborder of the manubrium\n#L1 and #R1 limited by the midline of the trachea.\n#2 (Left/Right) Upper paratracheal nodes\n2R: Upper border: Apex of lung and pleural space and, in the midline,\nthe upper border of the manubrium\nLower border: Intersection of caudal margin of innominate vein with\nthe trachea\n2L: Upper border: Apex of the lung and pleural space and, in the\nmidline, the upper border of the manubrium\nLower border: Superior border of the aortic arch\nAs for #4, in #2 the oncologic midline is along the left lateral border\nof the trachea.\n#3 Pre-vascular and retrotracheal nodes\n3a: Prevascular \u2013 On the right\nUpper border: Apex of chest\nLower border: Level of carina\nAnterior border: Posterior aspect of sternum\nPosterior border: Anterior border of superior vena cava\n3a: Prevascular \u2013 On the left\nUpper border: Apex of chest\nLower border: Level of carina\nAnterior border: Posterior aspect of sternum\nPosterior border: Left carotid artery\n3p: Retrotracheal\nUpper border: Apex of chest\nLower border: Carina\n#4 (Left/Right) Lower paratracheal nodes\n4R: Includes right paratracheal nodes, and pretracheal nodes extend-\ning to the left lateral border of trachea\nUpper border: Intersection of caudal margin of innominate vein with\nthe trachea\nLower border: Lower border of azygos vein\n4L: Includes nodes to the left of the left lateral border of the trachea,\nmedial to the ligamentum arteriosum\nUpper border: Upper margin of the aortic arch\nLower border: Upper rim of the left main pulmonary artery\n#5 Subaortic (aorto-pulmonary window)\nSubaortic lymph nodes lateral to the ligamentum arteriosum\nUpper border: The lower border of the aortic arch\nLower border: Upper rim of the left main pulmonary artery\n#6 Para-aortic nodes (ascending aorta or phrenic)\nLymph nodes anterior and lateral to the ascending aorta and aortic\narch\nUpper border: A line tangential to the upper border of the aortic arch\nLower border: The lower border of the aortic arch\n#7 Subcarinal nodes\nUpper border: The carina of the trachea\nLower border: The upper border of the lower lobe bronchus on the\nleft; the lower border of the bronchus intermedius on the right\n#8 (Left/Right) Para-esophageal nodes (below carina)\nNodes lying adjacent to the wall of the esophagus and to the right or\nleft of the midline, excluding subcarinal nodes\nUpper border: The upper border of the lower lobe bronchus on the\nleft; the lower border of the bronchus intermedius on the right\nLower border: The diaphragm\n#9 (Left/Right) Pulmonary ligament nodes\nNodes lying within the pulmonary ligament\nUpper border: The inferior pulmonary vein\nLower border: The diaphragm\n#10 (Left/Right) Hilar nodes\nIncludes nodes immediately adjacent to the mainstem bronchus and\nhilar vessels including the proximal portions of the pulmonary veins\nand main pulmonary artery\nUpper border: The lower rim of the azygos vein on the right; upper\nrim of the pulmonary artery on the left\nLower border: Interlobar region bilaterally\n#11 Interlobar nodes\nBetween the origin of the lobar bronchi\n*#11s: Between the upper lobe bronchus and bronchus intermedius\non the right\n*#11i: Between the middle and lower lobe bronchi on the right\n*optional sub-categories\n#12 Lobar nodes\nAdjacent to the lobar bronchi\n#13 Segmental nodes\nAdjacent to the segmental bronchi\n#14 Sub-segmental nodes\nAdjacent to the subsegmental bronchi\nRusch VW, Asamura H, Watanabe H, et al. The IASLC lung cancer\nstaging project: A proposal for a new international lymph\nnode map in the forthcoming seventh edition of the TNM\nclassification for lung cancer. J Thorac Oncol. 2009;4:568-577.", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724113", "page": 9, "cancer_type": "Unknown", "category": "Unknown", "cancer_site": "N1 NODES", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 3871}}
{"chunk_id": "tnm_chunk_12", "text": "N1 NODES\n\nINTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724116", "page": 9, "cancer_type": "Unknown", "category": "Unknown", "cancer_site": "N1 NODES", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 66}}
{"chunk_id": "tnm_chunk_13", "text": "1.  Asamura H, Nishimura KK, Giroux DJ, et al. IASLC lung cancer staging project: The new database to inform revisions in the\n\nninth edition of the TNM classification of lung cancer. J Thorac Oncol. 2023;18(5):564-575.", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724121", "page": 11, "cancer_type": "Lung", "category": "Unknown", "cancer_site": "1.  Asamura H, Nishimura KK, Giroux DJ, et al. IASLC lung cancer staging project: The new database to inform revisions in the", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 218}}
{"chunk_id": "tnm_chunk_14", "text": "2.  Van Schil PE, Asamura H, Nishimura KK, et al. The IASLC lung cancer staging project: Proposals for the revisions of the T\n\ndescriptors in the forthcoming ninth edition of the TNM classification for lung cancer. J Thorac Oncol. 2024; 19(5):749-765.", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724125", "page": 11, "cancer_type": "Lung", "category": "Unknown", "cancer_site": "2.  Van Schil PE, Asamura H, Nishimura KK, et al. The IASLC lung cancer staging project: Proposals for the revisions of the T", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 251}}
{"chunk_id": "tnm_chunk_15", "text": "3.  Huang J, Osarogiagbon RU, Giroux DJ, et al. The International Association for the Study of Lung Cancer staging project for\n\nlung cancer: Proposals for the revision of the N descriptors in the forthcoming ninth edition of the TNM classification for lung\ncancer. J Thorac Oncol. 2024; 19(5):766-785.", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724129", "page": 11, "cancer_type": "Lung", "category": "Unknown", "cancer_site": "3.  Huang J, Osarogiagbon RU, Giroux DJ, et al. The International Association for the Study of Lung Cancer staging project for", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 301}}
{"chunk_id": "tnm_chunk_16", "text": "4.  Rusch VW, Asamura H, Watanabe H, et al. The IASLC lung cancer staging project: A proposal for a new international lymph\n\nnode map in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol. 2009;4:568-577.", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724133", "page": 11, "cancer_type": "Lung", "category": "Unknown", "cancer_site": "4.  Rusch VW, Asamura H, Watanabe H, et al. The IASLC lung cancer staging project: A proposal for a new international lymph", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 243}}
{"chunk_id": "tnm_chunk_17", "text": "5.  Fong KM, Rosenthal A, Giroux DJ, et al. The International Association for the Study of Lung Cancer staging project for lung\n\ncancer: Proposals for the revision of the M descriptors in the forthcoming ninth edition of the TNM classification of lung\ncancer. J Thorac Oncol. 2024; 19(5):786-802.", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724137", "page": 11, "cancer_type": "Lung", "category": "Unknown", "cancer_site": "5.  Fong KM, Rosenthal A, Giroux DJ, et al. The International Association for the Study of Lung Cancer staging project for lung", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 296}}
{"chunk_id": "tnm_chunk_18", "text": "6.  Rami-Porta R, Nishimura KK, Giroux DJ, et al. The International Association for the Study of Lung Cancer lung cancer staging\n\nproject: Proposals for revision of the TNM stage groups in the forthcoming (ninth) edition of the TNM classification for lung\ncancer. J Thorac Oncol. 2024; 19(7):1007-1027.\nStage Groups of the 9th Edition of the Tumor, Node, Metastasis (TNM)", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724141", "page": 11, "cancer_type": "Lung", "category": "Unknown", "cancer_site": "6.  Rami-Porta R, Nishimura KK, Giroux DJ, et al. The International Association for the Study of Lung Cancer lung cancer staging", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 371}}
{"chunk_id": "tnm_chunk_19", "text": "Classification of Lung Cancer\n\n9th Edition TNM Descriptors and Stages\nT/M\nCategories and Descriptors\nN0\nN1\nN2\nN3\nN2a\nN2b\nT1\nT1a \u22641 cm\nIA1\nIIA\nIIB\nIIIA\nIIIB\nT1b >1 to \u22642 cm\nIA2\nIIA\nIIB\nIIIA\nIIIB\nT1c >2 to \u22643 cm\nIA3\nIIA\nIIB\nIIIA\nIIIB\nT2\nT2a Visceral pleura / central invasion\nIB\nIIB\nIIIA\nIIIB\nIIIB\nT2a >3 to \u22644 cm\nIB\nIIB\nIIIA\nIIIB\nIIIB\nT2b >4 to \u22645 cm\nIIA\nIIB\nIIIA\nIIIB\nIIIB\nT3\nT3 >5 to \u22647 cm\nIIB\nIIIA\nIIIA\nIIIB\nIIIC\nT3 Invasion\nIIB\nIIIA\nIIIA\nIIIB\nIIIC\nT3 Same lobe separate tumor nodules\nIIB\nIIIA\nIIIA\nIIIB\nIIIC\nT4\nT4 >7 cm\nIIIA\nIIIA\nIIIB\nIIIB\nIIIC\nT4 Invasion\nIIIA\nIIIA\nIIIB\nIIIB\nIIIC\nT4 Ipsilateral separate tumor nodules\nIIIA\nIIIA\nIIIB\nIIIB\nIIIC\nM1\nM1a Contralateral tumor nodules\nIVA\nIVA\nIVA\nIVA\nIVA\nM1a Pleural / pericardial e\ufb00 usion, nodules\nIVA\nIVA\nIVA\nIVA\nIVA\nM1b Single extrathoracic metastasis\nIVA\nIVA\nIVA\nIVA\nIVA\nM1c1 Multiple metastases in 1 organ system\nIVB\nIVB\nIVB\nIVB\nIVB\nM1c2 Multiple metastases in >1 organ systems\nIVB\nIVB\nIVB\nIVB\nIVB\n\nINTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER\nIASLC Staging Manual in Thoracic Oncology - download\nFunding support for the 9th Edition of the IASLC Staging Project\nwas generously provided by AstraZeneca\nScan the QR code to download the\naccompanying Staging Manual in\nThoracic Oncology, 3rd Edition!\n\nINTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724144", "page": 11, "cancer_type": "Lung", "category": "Unknown", "cancer_site": "Classification of Lung Cancer", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 1315}}
{"chunk_id": "tnm_chunk_20", "text": "Thymic Epithelial Tumors T Classi\ufb01 cation\u20139th Edition\n\nFigure. Courtesy of International Association for the Study of Lung Cancer. Permission must be requested and granted before\nphotocopying or reproducing this material for distribution. Copyright \u00a92024 Aletta Ann Frazier, MD.\nT1\nT2\n\nINTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724150", "page": 13, "cancer_type": "Thymic", "category": "Unknown", "cancer_site": "Thymic Epithelial Tumors T Classi\ufb01 cation\u20139th Edition", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 340}}
{"chunk_id": "tnm_chunk_21", "text": "Thymic Epithelial Tumors T Classi\ufb01 cation\u20139th Edition\n\nT4\nT3\nOkumura M, Marino M, Cilento V, et al. The International Association for the Study of Lung Cancer thymic epithelial tumor\nstaging project: Proposal for the T component for the forthcoming ninth edition of the TNM classification of malignant tumors. J\nThorac Oncol. 2023;18(12):1638-1654.\n\nINTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724155", "page": 14, "cancer_type": "Thymic", "category": "Unknown", "cancer_site": "Thymic Epithelial Tumors T Classi\ufb01 cation\u20139th Edition", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 404}}
{"chunk_id": "tnm_chunk_22", "text": "Thymic Epithelial Tumors N Classi\ufb01 cation\u20139th Edition\n\nFigure. Courtesy of International Association for the Study of Lung Cancer. Permission must be requested and granted before\nphotocopying or reproducing this material for distribution. Copyright \u00a92024 Aletta Ann Frazier, MD.\nFang W, Girard N, Cilento V, et al. The International Association for the Study of Lung Cancer thymic epithelial tumors staging\nproject: Proposals for the N and the M components for the forthcoming ninth edition of the TNM classification of malignant\ntumors. J Thorac Oncol. 2023;19(1):52-70.\nN1\nN2\n\nINTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724160", "page": 15, "cancer_type": "Thymic", "category": "Unknown", "cancer_site": "Thymic Epithelial Tumors N Classi\ufb01 cation\u20139th Edition", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 633}}
{"chunk_id": "tnm_chunk_23", "text": "Thymic Epithelial Tumors M Classi\ufb01 cation\u20139th Edition\n\nFang W, Girard N, Cilento V, et al. The International Association for the Study of Lung Cancer thymic epithelial tumors staging\nproject: Proposals for the N and the M components for the forthcoming ninth edition of the TNM classification of malignant\ntumors. J Thorac Oncol. 2023;19(1):52-70.\nM1b\nM1a\n\nINTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724164", "page": 16, "cancer_type": "Thymic", "category": "Unknown", "cancer_site": "Thymic Epithelial Tumors M Classi\ufb01 cation\u20139th Edition", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 411}}
{"chunk_id": "tnm_chunk_24", "text": "Thymic Epithelial Tumors\u20139th Edition\n\nITMIG: International Thymic Malignancy Interest Group.\nFigure. Courtesy of International Association for the Study of Lung Cancer. Permission must be requested and granted before\nphotocopying or reproducing this material for distribution.\nAxial #1\nAxial #2\nITMIG Mediastinal Compartments\nPrevascular compartment\nVisceral compartment\nParavertebral compartment\nVisceral-paravertebral boundary\nAo:  aorta\nPA:  pulmonary artery\nSVC:  superior vena cava\n\nT:  trachea\n\nAz:  azygos vein\nOes:  esophagus\nRMB:  right main bronchus\nLMB:  lef  main bronchus\nLA:  lef  atrium\nRV:  right ventricle\n\nINTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724169", "page": 17, "cancer_type": "Thymic", "category": "Unknown", "cancer_site": "Thymic Epithelial Tumors\u20139th Edition", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 678}}
{"chunk_id": "tnm_chunk_25", "text": "Thymic Epithelial Tumors\u20139th Edition\n\nITMIG Mediastinal Compartments\nPrevascular compartment\nVisceral compartment\nParavertebral compartment\nVisceral-paravertebral boundary\nAo:  aorta\nPA:  pulmonary artery\nSVC:  superior vena cava\n\nT:  trachea\n\nAz:  azygos vein\nOes:  esophagus\nRMB:  right main bronchus\nLMB:  lef  main bronchus\nLA:  lef  atrium\nRV:  right ventricle\nAxial #3\nSagittal\nCarter B, Tomiyama N, Bhora F et al. A Modern Definition of Mediastinal Compartments. J Thorac Oncol. 2014; 9(9): S97-S101.\nITMIG: International Thymic Malignancy Interest Group.\n\nINTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724173", "page": 18, "cancer_type": "Thymic", "category": "Unknown", "cancer_site": "Thymic Epithelial Tumors\u20139th Edition", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 618}}
{"chunk_id": "tnm_chunk_26", "text": "Thymic Epithelial Tumor TNM De\ufb01 nitions\u20139th Edition\n\nT category\nDescriptor*\nT1\nA tumor that is limited to the thymus with or\nwithout encapsulation, directly invades into\nthe mediastinal fat only or directly invades the\nmediastinal pleura but does not involve any\nother mediastinal structure.\nT1 is subdivided into\n1. T1a (5 cm or less in its greatest dimension)\n2. T1b (larger than 5 cm in its greatest\ndimension) irrespective of mediastinal\npleura (MP) invasion.\nLevel 1 structures\u2014thymus, anterior mediastinal\nfat, mediastinal pleura\nT2\nTumor directly invades the pericardium (either\npartial or full-thickness), or the lung or the\nphrenic nerve.\nLevel 2 structures\u2014pericardium, lung, phrenic\nnerve\nT3\nTumor directly invades any of the following:\n1) Brachiocephalic vein, 2) Superior vena cava,\n3) Chest wall or 4) Extrapericardial pulmonary\narteries or veins.\nLevel 3 structures\u2014brachiocephalic vein, SVC,\nchest wall, hilar pulmonary vessels\nT4\nTumor directly invades any of the following:\n1) Aorta (ascending, arch, or descending), 2)\nArch vessels, 3) Intrapericardial pulmonary\nartery or veins, 4) Myocardium, 5) Trachea, or\n6) Esophagus.\nLevel 4 structures\u2014aorta (ascending, arch,\nor descending], arch vessels, intrapericardial\npulmonary artery or veins, myocardium,\ntrachea, esophagus)\n*T categories are de\ufb01 ned by \u201clevels\u201d of invasion; they re\ufb02 ect the highest\ndegree of invasion regardless of how many other (lower level) structures\nare invaded.\nN category\nDescriptor*\nN0\nNo nodal involvement\nN1\nAnterior (perithymic) nodes\nN2\nDeep intrathoracic or cervical nodes\n* Involvement must be pathologically proven in pathologic staging.\nTNM, tumor, node, metastasis.\nM category\nDescriptor\nM0\nNo metastatic pleural, pericardial, or\ndistant sites\nM1\nDistant metastasis\nM1a\nSeparate pleural or pericardial nodule(s)\nM1b\nPulmonary intraparenchymal nodule or\ndistant organ metastasis*\n*Involvement of non-regional lymph nodes is staged as M1b.\nTNM, tumor, node, metastasis\n\nINTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724178", "page": 19, "cancer_type": "Thymic", "category": "TNM-staging", "cancer_site": "Thymic Epithelial Tumor TNM De\ufb01 nitions\u20139th Edition", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 2025}}
{"chunk_id": "tnm_chunk_27", "text": "1. Okumura M, Marino M, Cilento V, et al. The International Association for the Study of Lung Cancer thymic epithelial tumor\n\nstaging project: Proposal for the T component for the forthcoming (ninth) edition of the TNM classification of malignant tumors.\nJ Thorac Oncol. 2023;18(12):1638-1654.", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724182", "page": 20, "cancer_type": "Lung", "category": "Unknown", "cancer_site": "1. Okumura M, Marino M, Cilento V, et al. The International Association for the Study of Lung Cancer thymic epithelial tumor", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 293}}
{"chunk_id": "tnm_chunk_28", "text": "2. Fang W, Girard N, Cilento V, et al. The International Association for the Study of Lung Cancer thymic epithelial tumors staging\n\nproject: Proposals for the N and the M components for the forthcoming (ninth) edition of the TNM classification of malignant\ntumors. J Thorac Oncol. 2023;19(1):52-70.", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724186", "page": 20, "cancer_type": "Lung", "category": "Unknown", "cancer_site": "2. Fang W, Girard N, Cilento V, et al. The International Association for the Study of Lung Cancer thymic epithelial tumors staging", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 298}}
{"chunk_id": "tnm_chunk_29", "text": "3. Ru\ufb00 ini E, Huang J, Cilento V. The International Association for the Study of Lung Cancer thymic epithelial tumors staging\n\nproject: Proposal for a stage classification for the forthcoming (ninth) edition of the TNM classification of malignant tumors. J\nThorac Oncol. 2023;18(12):1655-1671", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724191", "page": 20, "cancer_type": "Lung", "category": "Unknown", "cancer_site": "3. Ru\ufb00 ini E, Huang J, Cilento V. The International Association for the Study of Lung Cancer thymic epithelial tumors staging", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 292}}
{"chunk_id": "tnm_chunk_30", "text": "4. Marom EM, Fang V, Ru\ufb00 ini E. The International Association for the Study of Lung Cancer thymic epithelial tumor staging\n\nproject: A re-assessment of the International Thymic Malignancy Interest Group/International Association for the Study of Lung\nCancer lymph node map for thymic epithelial tumors for the forthcoming ninth edition of the TNM classification of malignant\ntumors. J Thorac Oncol. 2023;18(12):1672-1688.", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724196", "page": 20, "cancer_type": "Lung", "category": "Unknown", "cancer_site": "4. Marom EM, Fang V, Ru\ufb00 ini E. The International Association for the Study of Lung Cancer thymic epithelial tumor staging", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 421}}
{"chunk_id": "tnm_chunk_31", "text": "5. Bhora FY, Chen DJ, Detterbeck FC. The ITMIG/IASLC Thymic Epithelial Tumors Staging Project: A Proposed Lymph Node Map\n\nfor Thymic Epithelial Tumors in the Forthcoming 8th Edition of the TNM Classification of Malignant Tumors. J Thorac Oncol.\n2014;9(9Suppl 2): S88-S96.", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724201", "page": 20, "cancer_type": "Thymic", "category": "Unknown", "cancer_site": "5. Bhora FY, Chen DJ, Detterbeck FC. The ITMIG/IASLC Thymic Epithelial Tumors Staging Project: A Proposed Lymph Node Map", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 271}}
{"chunk_id": "tnm_chunk_32", "text": "6. Rusch V, Asamura H, Watanabe H. The IASLC lung cancer staging project: A proposal for a new international lymph node map\n\nin the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol. 2009;4(5):568-577.\nStage\nT category\nN category\nM category\nI\nT1a-b\nN0\nM0\nII\nT2\nN0\nM0\nIIIA\nT3\nN0\nM0\nIIIB\nT4\nN0\nM0\nIVA\nT any\nT any\nN1\nN0,N1\nM0\nM1a\nIVB\nT any\nT any\nN2\nN any\nM0, M1a\nM1b\nNote: any invasion must be histologically con\ufb01 rmed for pathologic stage\nTNM, tumor, node, metastasis\nThymic Epithelial Tumor Stage Groups \u2013 9th Edition\n\nITMIG/IASLC Lymph Node Map\nLower Neck/Cricoid\nCartilage Level\nFigure 1. Lymph node\nlevels at the lower neck,\nbelow the level of the\ncricoid cartilage. N1\nregion (blue) and N2\nregion (red). LAC, low\nanterior cervical region;\nPJ, peri-jugular region;\nSC, supraclavicular\nregion; T, thyroid\nLower Neck/\nMid Trachea Level\nFigure 2. Lymph node\nlevels at the lower neck,\nmid trachea level. N1\nregion (blue) and N2\nregion (red). LAC, low\nanterior cervical region;\nPJ, peri-jugular region;\nSC, supraclavicular\nregion; T, thyroid\nAortic Arch Level\nFigure 3. Shaded lymph node groups\nat the level of the aortic arch. N1\nregion (blue) and N2 region (red).\nIM, internal mammary node group.\nNumbers 3, 4, 6 refer to IASLC node\nmap used for lung cancer.\nLower Neck/Cricoid\nITMIG/IASLC Lymph Node Map\nINTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724205", "page": 20, "cancer_type": "Lung", "category": "Unknown", "cancer_site": "6. Rusch V, Asamura H, Watanabe H. The IASLC lung cancer staging project: A proposal for a new international lymph node map", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 1394}}
{"chunk_id": "tnm_chunk_33", "text": "Thymic Epithelial Tumors\u20139th Edition\n\nINTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724210", "page": 21, "cancer_type": "Thymic", "category": "Unknown", "cancer_site": "Thymic Epithelial Tumors\u20139th Edition", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 92}}
{"chunk_id": "tnm_chunk_34", "text": "Thymic Epithelial Tumors\u20139th Edition\n\nITMIG/IASLC Lymph Node Map\nAorto-Pulmonary Window Level\nFigure 4. Shaded lymph node groups at\nthe level of the aorto-pulmonary window.\nN1 region (blue) and N2 region (red). IM,\ninternal mammary node group. Numbers\n3, 4, 5 refer to IASLC node map used for\nlung cancer.\nMain Pulmonary Artery Level\nFigure 5. Shaded lymph node groups at\nthe level of the main pulmonary artery.\nN1 region (blue) and N2 region (red). IM,\ninternal mammary node group. Numbers\n3, 7, 10R refer to IASLC node map used for\nlung cancer.\nLower Chest (base of the heart)\nLevel\nFigure 6. Native and shaded CT in the\nLower chest demonstrating the anterior\n(perithymic) region (N1)(blue).\nMarom EM, Fang V, Ru\ufb00  ini E. The International\nAssociation for the Study of Lung Cancer thymic\nepithelial tumor staging project: A re-assessment\nof the International Thymic Malignancy Interest\nGroup/International Association for the Study\nof Lung Cancer lymph node map for thymic\nepithelial tumors for the forthcoming ninth\nedition of the TNM classification of malignant\ntumors. J Thorac Oncol. 2023;18(12):1672-1688.\n\nGill RR, Nowak AK, Giroux DJ, et al. The International Association for the Study of Lung Cancer mesothelioma staging\nproject: Proposals for revisions of the \u201cT\u201d descriptors in the forthcoming ninth edition of the TNM classification for pleural\nmesothelioma. J Thorac Oncol. 2024;S1556-0864.\nINTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724214", "page": 22, "cancer_type": "Thymic", "category": "Unknown", "cancer_site": "Thymic Epithelial Tumors\u20139th Edition", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 1459}}
{"chunk_id": "tnm_chunk_35", "text": "Pleural Mesothelioma T Classi\ufb01 cation\u20139th Edition\n\nT1\nT2\nT3\nT4\ncT2: Tumor involving the ipsilateral pleura with\nPsuma \u226412mm and with any of the following:\n\u2022  involvement of the \ufb01 ssure (Fmaxb >5mm)\n\u2022  mediastinal fat invasion\n\u2022  solitary area of chest wall soft tissue invasion;\nor\nTumor involving the ipsilateral pleura with\nPsuma >12mm but \u226430mm, with or without:\n\u2022  involvement of the \ufb01 ssure (Fmaxb >5mm)\n\u2022  mediastinal fat invasion\n\u2022  solitary area of chest wall soft tissue invasion\npT2: Tumor involving the ipsilateral pleura and\nwith any of the following:\n\u2022 involvement of the \ufb01 ssure\n\u2022 ipsilateral lung parenchyma invasion\n\u2022 diaphragm (non-transmural) invasion\nCLINICAL T (cT)\ncT1: Tumor limited to the\nipsilateral pleura with Psuma\n\u226412mm with no involvement of\nthe \ufb01 ssure (Fmaxb \u22645mm)\nPATHOLOGICAL T (pT)\npT1: Tumor limited to the\nipsilateral pleura with no\ninvolvement of the \ufb01 ssure\ncT3: Tumor involving the\nipsilateral pleura with Psuma >\n30 mm; with or without:\n\u2022  involvement of the \ufb01 ssure\n(Fmaxb >5mm)\n\u2022  mediastinal fat invasion\n\u2022  solitary area of chest wall\nsoft tissue invasion\npT3: Tumor limited to the\nipsilateral pleura (with or\nwithout \ufb01 ssure involvement)\nand with invasion of any of\nthe following:\n\u2022 mediastinal fat\n\u2022 surface of pericardium\n\u2022  endothoracic fascia\n\u2022 solitary area of chest wall\nsoft tissue\ncT4: Tumor with invasion of any of the\nfollowing (any Psuma):\n\u2022 chest wall bony invasion (rib)\n\u2022  mediastinal organs (heart, spine,\nesophagus, trachea, great vessels)\n\u2022 di\ufb00 use chest wall invasion\n\u2022  direct tumor extension through the\ndiaphragm or pericardium\n\u2022  direct extension to the contralateral pleura\n\u2022  presence of malignant pericardial e\ufb00 usion\npT4: Tumor with invasion of any of the\nfollowing:\n\u2022 chest wall bony invasion (rib)\n\u2022  mediastinal organs (heart, spine\nesophagus, trachea, great vessels)\n\u2022 di\ufb00 use chest wall invasion\n\u2022  transmural invasion of the diaphragm or\npericardium\n\u2022  direct extension to the contralateral pleura\n\u2022  presence of malignant pericardial e\ufb00 usion\n\nINTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724219", "page": 23, "cancer_type": "Unknown", "category": "Unknown", "cancer_site": "Pleural Mesothelioma T Classi\ufb01 cation\u20139th Edition", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 2076}}
{"chunk_id": "tnm_chunk_36", "text": "Pleural Mesothelioma N Classi\ufb01 cation\u20139th Edition\n\nMetastases to ipsilateral intrathoracic lymph nodes\n(includes ipsilateral bronchopulmonary, hilar, subcarinal,\nparatracheal, aortopulmonary, para-esophageal,\nperidiaphragmatic, pericardial fat pad, intercostal, and\ninternal mammary nodes)\nN2\nN1\nNodal groups\n\u2022 Anterior pericardial fat pad\n\u2022 Fat pad adjacent to IVC\n\u2022 Posterior intercostal nodes\n\u2022 Posterior costophrenic angle\nLateral N1\nMetastases in the contralateral\nmediastinal, ipsilateral or contralateral\nsupraclavicular lymph nodes\nBill\u00e8 AR, Ripley RT, Giroux DJ, et al. Proposals for the N descriptors in the forthcoming 9th edition of the TNM classification for\npleural mesothelioma. J Thorac Oncol. in press 2024.\nFigure. Courtesy of International Association for the Study of Lung Cancer. Permission must be requested and granted before\nphotocopying or reproducing this material for distribution.\n\nINTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724224", "page": 24, "cancer_type": "Unknown", "category": "Unknown", "cancer_site": "Pleural Mesothelioma N Classi\ufb01 cation\u20139th Edition", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 964}}
{"chunk_id": "tnm_chunk_37", "text": "Primary Tumor (T)\n\nCategory\nClinical T (cT)\nPathologic T (pT)\nTx\nTumor cannot be assessed\nT0\nNo tumor is present\nT1\nTumor limited to the ipsilateral pleura with Psuma \u226412\nmm with no involvement of the \ufb01 ssure (Fmaxb \u22645 mm)\nTumor limited to the ipsilateral pleura with no\ninvolvement of the \ufb01 ssure\nT2\nTumor involving the ipsilateral pleura with Psuma \u226412\nmm and with any of the following:\n\u2022 Involvement of the \ufb01 ssure (Fmaxb >5 mm)\n\u2022 Mediastinal fat invasion\n\u2022 Solitary area of chest wall soft tissue invasion\nor\nTumor involving the ipsilateral pleura with Psuma >12\nmm but \u226430 mm, with or without:\n\u2022 Involvement of the \ufb01 ssure (Fmaxb >5 mm)\n\u2022 Mediastinal fat invasion\n\u2022 Solitary area of chest wall soft tissue invasion\nTumor involving the ipsilateral pleura and with any of\nthe following:\n\u2022 Involvement of the \ufb01 ssure\n\u2022 Ipsilateral lung parenchyma invasion\n\u2022 Diaphragm (non-transmural) invasion\nT3\nTumor involving the ipsilateral pleura with Psuma\u00a0>30\nmm; with or without:\n\u2022 Involvement of the \ufb01 ssure (Fmaxb>5mm)\n\u2022 Mediastinal fat invasion\n\u2022 Solitary area of chest wall soft tissue invasion\nTumor limited to the ipsilateral pleura (with or without\n\ufb01 ssure involvement) and with invasion of any of the\nfollowing:\n\u2022 Mediastinal fat\n\u2022 Surface of pericardium\n\u2022 Endothoracic fascia\n\u2022 Solitary area of chest wall soft tissue\nCategory\nClinical T (cT)\nPathologic T (pT)\nT4\nTumor with invasion of any of the following (any Psuma):\n\u2022 Chest wall bony invasion (rib)\n\u2022 Mediastinal organs (heart, spine, esophagus,\ntrachea, great vessels)\n\u2022 Di\ufb00 use chest wall invasion\n\u2022 Direct tumor extension through the diaphragm or\npericardium\n\u2022 Direct extension to the contralateral pleura\n\u2022 Presence of malignant pericardial e\ufb00 usion\nTumor with invasion of any of the following:\n\u2022 Chest wall bony invasion (rib)\n\u2022 Mediastinal organs (heart, spine esophagus, trachea,\ngreat vessels)\n\u2022 Di\ufb00 use chest wall invasion\n\u2022 Transmural invasion of the diaphragm or pericardium\n\u2022 Direct extension to the contralateral pleura\n\u2022 Presence of malignant pericardial e\ufb00 usion\na Psum = pmax1 + pmax2 + pmax3 (sum of 3 measurements of maximal pleural thickness measured on axial images along the chest wall or\nmediastinum in each of the three divisions of the chest \u2013 upper, middle and lower divided by two lines; one at the top of the aortic arch and\nthe second drawn at the top of the left atrium)\nb Fmax = maximal thickness of pleural tumor along the \ufb01 ssures measured on sagittal images\n\nINTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724228", "page": 25, "cancer_type": "Unknown", "category": "Unknown", "cancer_site": "Primary Tumor (T)", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 2504}}
{"chunk_id": "tnm_chunk_38", "text": "1. Wolf AS, Eisele M, Giroux DJ, et al. The International Association for the Study of Lung Cancer pleural mesothelioma staging\n\nproject: Expanded database to inform revisions in the ninth edition of the TNM classification of pleural mesothelioma. J Thorac\nOncol. 2024;S1556-0864.", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724232", "page": 26, "cancer_type": "Lung", "category": "Unknown", "cancer_site": "1. Wolf AS, Eisele M, Giroux DJ, et al. The International Association for the Study of Lung Cancer pleural mesothelioma staging", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 280}}
{"chunk_id": "tnm_chunk_39", "text": "2. Gill RR, Nowak AK, Giroux DJ, et al. The International Association for the Study of Lung Cancer mesothelioma staging\n\nproject: Proposals for revisions of the \u201cT\u201d descriptors in the forthcoming ninth edition of the TNM classification for pleural\nmesothelioma. J Thorac Oncol. 2024;S1556-0864.", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724236", "page": 26, "cancer_type": "Lung", "category": "Unknown", "cancer_site": "2. Gill RR, Nowak AK, Giroux DJ, et al. The International Association for the Study of Lung Cancer mesothelioma staging", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 294}}
{"chunk_id": "tnm_chunk_40", "text": "3. Bille AR, Ripley RT, Giroux DJ, et al. Proposals for the N descriptors in the forthcoming 9th edition of the TNM classification for\n\npleural mesothelioma. J Thorac Oncol. in press 2024.", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724241", "page": 26, "cancer_type": "Unknown", "category": "M-staging", "cancer_site": "3. Bille AR, Ripley RT, Giroux DJ, et al. Proposals for the N descriptors in the forthcoming 9th edition of the TNM classification for", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 188}}
{"chunk_id": "tnm_chunk_41", "text": "4. Kindler HL, Rosenthal A, Giroux DJ, et al. The IASLC Mesothelioma staging project: Proposals for the M descriptors in the\n\nforthcoming ninth edition the TNM classification for pleural mesothelioma. J Thorac Oncol., in press 2024.", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724247", "page": 26, "cancer_type": "Unknown", "category": "Unknown", "cancer_site": "4. Kindler HL, Rosenthal A, Giroux DJ, et al. The IASLC Mesothelioma staging project: Proposals for the M descriptors in the", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 232}}
{"chunk_id": "tnm_chunk_42", "text": "5. Nowak AK, Giroux DJ, Eisele M, et al. The IASLC Pleural Mesothelioma Staging Project: Proposal for revision of the TNM stage\n\ngroupings in the forthcoming ninth edition of the TNM classification for pleural mesothelioma. J Thorac Oncol, in press 2024.\nN0\nN1\nN2\nT1\nI\nII\nIIIA\nT2\nII\nIIIA\nIIIA\nT3\nIIIA\nIIIA\nIIIA\nT4\nIIIB\nIIIB\nIIIB\nM1\nIV\nIV\nIV", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724252", "page": 26, "cancer_type": "Unknown", "category": "M-staging", "cancer_site": "5. Nowak AK, Giroux DJ, Eisele M, et al. The IASLC Pleural Mesothelioma Staging Project: Proposal for revision of the TNM stage", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 340}}
{"chunk_id": "tnm_chunk_43", "text": "Pleural Mesothelioma TNM Stages\u20139th Edition\n\nN Category\nClinical (cN) and pathologic (pN) N\ndescriptors\nNX\nRegional lymph nodes cannot be assessed\nN0\nNo regional lymph node metastasis\nN1\nMetastases to ipsilateral intrathoracic\nlymph nodes (includes ipsilateral broncho-\npulmonary, hilar, subcarinal, paratracheal,\naortopulmonary, para-esophageal, peridia-\nphragmatic, pericardial fat pad, intercostal,\nand internal mammary nodes)\nN2\nMetastases to contralateral lymph nodes.\nMetastases to ipsilateral or contralateral\nsupraclavicular lymph nodes\nM Category\nClinical M descriptor (cM)\nM0\nNo distant metastasis\nM1\nDistant metastasis present\n\nINTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER\nCancer of the Esophagus and Esophagogastric Junction\n9th Edition\nNinth edition TNM categories. T is categorized as Tis: high-grade dysplasia; T1: cancer invades\nlamina propria, muscularis mucosae, or submucosa and is subcategorized into T1a (cancer\ninvades lamina propria or muscularis mucosae) and T1b (cancer invades submucosa); T2: cancer\ninvades muscularis propria; T3: cancer invades adventitia; T4, cancer invades local structures and\nis subcategorized as T4a: cancer invades adjacent structures such as pleura, pericardium, azygos\nvein, diaphragm, or peritoneum and T4b: cancer invades major adjacent structures such as aorta,\nvertebral body, or trachea. N is categorized as N0: no regional lymph node metastasis; N1, regional\nlymph node metastases involving 1 to 2 nodes; N2, regional lymph node metastases involving 3 to\n6 nodes; and N3, regional lymph node metastases involving 7 or more nodes. M is categorized as\nM0: no distant metastasis; and M1: distant metastasis.\n1. AJCC Cancer Staging Manual. 8th ed. Amin MB, Edge S, Greene FL, et al., eds. New York: Springer, 2017.\n2. TNM Classification of Malignant Tumours, 8th Edition. Brierley JD, Gospodarowicz MK, Wittekind C, eds. London: Wiley, 2016.\n3. Rice TW, Ishwarran H, Ferguson MK, et al. Cancer of the esophagus and esophageal junction: An 8th edition staging primer.\nJ Thorac Oncol. 2016; 12(1):36-42.\nCopyright \u00a92016 Cleveland Clinic Foundation, courtesy of Thomas W. Rice, MD.", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724257", "page": 26, "cancer_type": "Unknown", "category": "M-staging", "cancer_site": "Pleural Mesothelioma TNM Stages\u20139th Edition", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 2145}}
{"chunk_id": "tnm_chunk_44", "text": "Pleural Mesothelioma TNM Stages\u20139th Edition\n\nINTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER\nCancer of the Esophagus and Esophagogastric Junction\n9th Edition\nT Category\nDescriptor\nTX\nPrimary tumor cannot be assessed\nT0\nNo evidence of primary tumor\nTis\nCarcinoma in situ/high-grade dysplasia\nT1\nTumor invades lamina propria, muscularis mucosa, or submucosa\nT1a\nTumor invades lamina propria or muscularis mucosa\nT1b\nTumor invades submucosa\nT2\nTumor invades muscularis propria\nT3\nTumor invades adventitia\nT4\nTumor invades adjacent structures\nT4a\nTumor invades pleura, pericardium, azygos vein, diaphragm, or peritoneum (resectable)\nT4b\nTumor invades other adjacent structures such as aorta, vertebral body, or trachea (non-resectable)\nN Category\nDescriptor\nNX\nRegional lymph nodes cannot be assessed\nN0\nNo regional lymph node metastasis\nN1\nMetastasis in 1 - 2 regional lymph nodes\nN2\nMetastasis in 3 - 6 regional lymph nodes\nN3\nMetastasis in 7 or more regional lymph nodes\nM Category\nDescriptor\nM0\nNo distant metastasis\nM1\nDistant metastasis\nTNM De\ufb01 nitions\n\nINTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER\nCancer of the Esophagus and Esophagogastric Junction\n9th Edition\nCopyright \u00a92016 Cleveland Clinic Foundation, courtesy of Thomas W. Rice, MD.\nC\nA\nB\nLymph Node Map", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724262", "page": 26, "cancer_type": "Unknown", "category": "M-staging", "cancer_site": "Pleural Mesothelioma TNM Stages\u20139th Edition", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 1282}}
{"chunk_id": "tnm_chunk_45", "text": "Pleural Mesothelioma TNM Stages\u20139th Edition\n\nINTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER\nCancer of the Esophagus and Esophagogastric Junction\n9th Edition\n1. AJCC Cancer Staging Manual. 8th ed. Amin MB, Edge S, Greene FL, et al., eds. New York: Springer, 2017.\n2. TNM Classification of Malignant Tumours, 8th Edition. Brierley JD, Gospodarowicz MK, Wittekind C, eds. London: Wiley, 2016.\n3. Rice TW, Ishwarran H, Ferguson MK, et al. Cancer of the esophagus and esophageal junction: An 8th edition staging primer.\nJ Thorac Oncol. 2016; 12(1):36-42.\nCopyright \u00a92016 Cleveland Clinic Foundation, courtesy of Thomas W. Rice, MD.\nRegional lymph node stations for staging esophageal cancer from lef  (A), right (B), and anterior\n(C). 1R: Right lower cervical paratracheal nodes, between the supraclavicular paratracheal space\nand apex of the lung. 1L: Lef  lower cervical paratracheal nodes, between the supraclavicular\nparatracheal space and apex of the lung. 2R: Right upper paratracheal nodes, between the\nintersection of the caudal margin of the brachiocephalic artery with the trachea and apex of\nthe lung. 2L: Lef  upper paratracheal nodes, between the top of the aortic arch and apex of the\nlung. 4R: Right lower paratracheal nodes, between the intersection of the caudal margin of the\nbrachio cephalic artery with the trachea and cephalic border of the azygos vein. 4L: Lef  lower\nparatracheal nodes, between the top of the aortic arch and the carina. 7: Subcarinal nodes,\ncaudal to the carina of the trachea. 8U: Upper thoracic paraesophageal lymph nodes, from the\napex of the lung to the tracheal bifurcation. 8M: Middle thoracic paraesophageal lymph nodes,\nfrom the tracheal bifurcation to the caudal margin of the inferior pulmonary vein. 8Lo: Lower\nthoracic paraesophageal lymph nodes, from the caudal margin of the inferior pulmonary vein\nesophagogastric junction. 9R: Pulmonary ligament nodes, within the right inferior pulmonary\nligament. 9L: Pulmonary ligament nodes, within the lef  inferior pulmonary ligament. 15:\nDiaphragmatic nodes, lying on the dome of the diaphragm and adjacent to or behind its crura.\n16: Paracardial nodes, immediately adjacent to the gastroesophageal junction. 17: Lef  gastric\nnodes, along the course of the lef  gastric artery. 18: Common hepatic nodes, immediately on the\nproximal common hepatic artery. 19: Splenic nodes, immediately on the proximal splenic artery.\n20: Celiac nodes, at the base of the celiac artery. Cervical periesophageal level VI and level VII\nlymph nodes are named as per the head and neck map.\nLymph Node Legend", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724266", "page": 26, "cancer_type": "Unknown", "category": "M-staging", "cancer_site": "Pleural Mesothelioma TNM Stages\u20139th Edition", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 2588}}
{"chunk_id": "tnm_chunk_46", "text": "Pleural Mesothelioma TNM Stages\u20139th Edition\n\nINTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER\nCancer of the Esophagus and Esophagogastric Junction\n9th Edition\nExact measurements depend on body size and height. Location of cancer primary site is defined by\ncancer epicenter. Cancers involving the esophagogastric junction (EGJ) that have their epicenter within\nthe proximal 2 cm of the cardia (Siewert types I/II) are to be staged as esophageal cancers. Cancers whose\nepicenter is more than 2 cm distal from the EGJ, even if the EGJ is involved, will be staged using the\nstomach cancer TNM and stage groups.\nKey: LES, lower esophageal sphincter; UES, upper esophageal sphincter.\nRice TW, Ishwarran H, Ferguson MK, et al. Cancer of the esophagus and esophageal junction: An 8th edition staging primer.\nJ Thorac Oncol. 2016; 12(1):36-42.\nCopyright \u00a92016 Cleveland Clinic Foundation, courtesy of Thomas W. Rice, MD.", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724270", "page": 26, "cancer_type": "Unknown", "category": "M-staging", "cancer_site": "Pleural Mesothelioma TNM Stages\u20139th Edition", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 919}}
{"chunk_id": "tnm_chunk_47", "text": "Location of Esophageal Cancer Primary Site\n\nINTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER\nCancer of the Esophagus and Esophagogastric Junction\n9th Edition\nClinical Stage for Squamous Cell Carcinoma of the Esophagus and the Esophagogastric Junction (cTNM)\nStage 0\nTis\nN0\nM0\nStage I\nT1", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724275", "page": 31, "cancer_type": "Unknown", "category": "Unknown", "cancer_site": "Location of Esophageal Cancer Primary Site", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 292}}
{"chunk_id": "tnm_chunk_48", "text": "N0, N1\n\nM0\nStage II\nT2", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724278", "page": 32, "cancer_type": "Unknown", "category": "Unknown", "cancer_site": "N0, N1", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 22}}
{"chunk_id": "tnm_chunk_49", "text": "N0, N1\n\nM0\nT3\nN0\nM0\nStage III", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724282", "page": 32, "cancer_type": "Unknown", "category": "Unknown", "cancer_site": "N0, N1", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 29}}
{"chunk_id": "tnm_chunk_50", "text": "T1, T2\n\nN2\nM0\nT3", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724285", "page": 32, "cancer_type": "Unknown", "category": "Unknown", "cancer_site": "T1, T2", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 16}}
{"chunk_id": "tnm_chunk_51", "text": "N1, N2\n\nM0\nStage IVA\nT4a, T4b", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724288", "page": 32, "cancer_type": "Unknown", "category": "Unknown", "cancer_site": "N1, N2", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 29}}
{"chunk_id": "tnm_chunk_52", "text": "N0, N1, N2\n\nM0\nAny T\nN3\nM0\nStage IVB\nAny T\nAny N\nM1\nClinical Stage for Adenocarcinoma of the Esophagus and the Esophagogastric Junction (cTNM)\nStage 0\nTis\nN0\nM0\nStage I\nT1\nN0\nM0\nStage IIA\nT1\nN1\nM0\nStage IIB\nT2\nN0\nM0\nStage III\nT2\nN1\nM0\nT3, T4a", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724292", "page": 32, "cancer_type": "Unknown", "category": "Unknown", "cancer_site": "N0, N1, N2", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 242}}
{"chunk_id": "tnm_chunk_53", "text": "N0, N1\n\nM0\nStage IVA\nT1-T4a\nN2\nM0\nT4b", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724295", "page": 32, "cancer_type": "Unknown", "category": "Unknown", "cancer_site": "N0, N1", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 37}}
{"chunk_id": "tnm_chunk_54", "text": "N0, N1, N2\n\nM0\nAny T\nN3\nM0\nStage IVB\nAny T\nAny N\nM1", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724299", "page": 32, "cancer_type": "Unknown", "category": "Unknown", "cancer_site": "N0, N1, N2", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 51}}
{"chunk_id": "tnm_chunk_55", "text": "1. Rice TW, Ishwaran H, Blackstone EH, et al. Recommendations for clinical staging (cTNM) of cancer of the esophagus and\n\nesophagogastric junction for the 8th edition AJCC/UICC staging manuals. Dis Esophagus. 2016;7:913-19.", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724303", "page": 32, "cancer_type": "Esophagus", "category": "TNM-staging", "cancer_site": "1. Rice TW, Ishwaran H, Blackstone EH, et al. Recommendations for clinical staging (cTNM) of cancer of the esophagus and", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 223}}
{"chunk_id": "tnm_chunk_56", "text": "2. Rice TW, Apperson-Hansen C, DiPaola LM, et al. Worldwide Esophageal Cancer Collaboration: Clinical staging data. Dis\n\nEsophagus. 2016;7:707-14.", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724309", "page": 32, "cancer_type": "Unknown", "category": "Unknown", "cancer_site": "2. Rice TW, Apperson-Hansen C, DiPaola LM, et al. Worldwide Esophageal Cancer Collaboration: Clinical staging data. Dis", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 146}}
{"chunk_id": "tnm_chunk_57", "text": "3. Rice TW, Ishwarran H, Ferguson MK, et al. Cancer of the esophagus and esophageal junction: An 8th edition staging primer. J\n\nThorac Oncol. 2016; 12(1):36-42.\nClinical Stage Groups (cTNM)\n\nINTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER\nCancer of the Esophagus and Esophagogastric Junction\n9th Edition\nRice TW, Ishwaran H, Hofstetter WL, et al. Recommendations for pathologic staging (pTNM) of cancer of the esophagus and\nesophagogastric junction for the 8th edition AJCC/UICC staging manuals. Dis Esophagus. 2016;7:897-905.\nPathologic Stage for Cancers of the Esophagus and the Esophagogastric Junction (pTNM)\nStage 0\nTis\nN0\nM0\nStage IA\nT1a\nN0\nM0\nStage IB\nT1b\nN0\nM0\nStage IIA\nT2\nN0\nM0\nStage IIB\nT1\nN1\nM0\nT3\nN0\nM0\nStage IIIA\nT1\nN2\nM0\nT2\nN1\nM0\nStage IIIB\nT2\nN2\nM0\nT3", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724313", "page": 32, "cancer_type": "Esophagus", "category": "Unknown", "cancer_site": "3. Rice TW, Ishwarran H, Ferguson MK, et al. Cancer of the esophagus and esophageal junction: An 8th edition staging primer. J", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 774}}
{"chunk_id": "tnm_chunk_58", "text": "N1, N2\n\nM0\nT4a", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724317", "page": 33, "cancer_type": "Unknown", "category": "Unknown", "cancer_site": "N1, N2", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 14}}
{"chunk_id": "tnm_chunk_59", "text": "N0, N1\n\nM0\nStage IVA\nT4a\nN2\nM0\nT4b\nAny N\nM0\nAnyT\nT3\nM0\nStage IVB\nAnyT\nAny N\nM1\nPathologic stage is similar for both squamous cell carcinoma and adenocarcinoma.\nPathologic Stage Groups (pTNM)\n\nINTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER\nCancer of the Esophagus and Esophagogastric Junction\n9th Edition\nRice TW, Ishwaran H, Kelsen DP, et al. Recommendations for neoadjuvant pathologic staging (ypTNM) of cancer of the\nesophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals. Dis Esophagus. 2016;29(8):906-912.\nPathologic Stage After Neoadjuvant Therapy for Cancers of the Esophagus and the Esophagogastric Junction (ypTNM)\nStage\nT\nN\nM\nStage I\nT0-2\nN0\nM0\nStage II\nT3\nN0\nM0\nStage IIIA\nT0-2\nN1\nM0\nStage IIIB\nT3\nN1\nM0\nT0-3\nN2\nM0\nT4a\nN0\nM0\nStage IVA\nT4a\nN1-2\nM0\nT4a\nNX\nM0\nT4b\nN0-2\nM0\nAny T\nN3\nM0\nStage IVB\nAny T\nAny N\nM1\nypStage is also identical for both histopathologic cell types.\nPostneoadjuvant Pathologic Stage Groups (ypTNM)\n\nINTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER\nCT Atlas\u20139th Edition\nRusch VW, Asamura H, Watanabe H, Giroux DJ, Rami-Porta R, Goldstraw P. The IASLC lung cancer staging project. A proposal\nfor a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac\nOncol. 2009; 4: 568-577.\nFigure. Courtesy of International Association for the Study of Lung Cancer. Permission must be requested and granted before\nphotocopying or reproducing this material for distribution. Copyright \u00a92024 Aletta Ann Frazier, MD.\nLtSPV \u2013 left superior pulmonary vein\nmPA \u2013 main pulmonary artery\nRtInV \u2013 right innominate vein\nRtMB \u2013 right mainstem bronchus\nRtPA \u2013 right pulmonary artery\nLtPA \u2013 left pulmonary artery\nSVC \u2013 superior vena cava\nT \u2013 trachea\nAbbreviations:\nAo\u2013 aorta\nAz \u2013 azygos vein\nEso \u2013 esophagus\nInV \u2013 innominate vein\nLLLB \u2013 lef  lower lobe bronchus\nLtInV \u2013 lef  innominate vein\nLtMB \u2013 lef  mainstem bronchus\nLtPA \u2013 lef  pulmonary artery\nLtSCA \u2013 lef  subclavian artery\nAxial #3\nAxial #2\nAxial #1\n\nINTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER\nCT Atlas\u20139th Edition\nAo\u2013 aorta\nAz \u2013 azygos vein\nEso \u2013 esophagus\nInV \u2013 innominate vein\nLLLB \u2013 lef  lower lobe bronchus\nLtInV \u2013 lef  innominate vein\nLtMB \u2013 lef  mainstem bronchus\nLtPA \u2013 lef  pulmonary artery\nLtSCA \u2013 lef  subclavian artery\nLtSPV \u2013 lef  superior pulmonary vein\nmPA \u2013 main pulmonary artery\nRtInV \u2013 right innominate vein\nRtMB \u2013 right mainstem bronchus\nRtPA \u2013 right pulmonary artery\nLtPA \u2013 lef  pulmonary artery\nSVC \u2013 superior vena cava\nT \u2013 trachea\nAbbreviations:\ncricoid cartilage\nmanubrium\nlevel of\ncarina\ncricoid cartilage\nmanubrium\nlevel of\ncarina\nlevel of\nbronchus\nintermedius\ncricoid\ncartilage\ncarina\nbronchus\nintermedius\nlower lobe\nbronchus\nmanubrium/\napex\nSagittal Lef\nSagittal Right\nCoronal", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724359", "page": 33, "cancer_type": "Unknown", "category": "Unknown", "cancer_site": "N0, N1", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 2785}}
{"chunk_id": "tnm_chunk_60", "text": "N0, N1\n\n2021 WHO Classification\nLung Adenocarcinoma in\nResected Specimens\nConquering Lung & Thoracic Cancers\nWorldwide in the 21st Century\nInvasive Non-Mucinous Lung Adenocarcinoma\nA\nC\nE\nB\nD\nF\nFigure 1. A. Macroscopic image of a subpleural tumour showing a solid component superiorly corresponding to invasive\nadenocarcinoma and a more ill-defined component inferiorly corresponding to a lepidic/non-invasive component. B. Lepidic\npattern adenocarcinoma. C. Papillary pattern with central fibrovascular cores. D. Acinar Pattern. E. Micropapillary pattern lacking\nfibrovascular cores. F. Solid pattern.\nReprinted with permission from WHO Classification of Tumours Editorial Board. Thoracic tumours. Lyon: IARC; 2021.\nFigure 2. Pie chart showing\nthe proportion of oncogenic\ndriver mutations nonmucinous\nadenocarcinoma of the lung from\neastern Asia and USA/Europe.\nTable 1. Grading of resected early-stage invasive non-mucinous lung adenocarcinoma based on histological patterns.\nGrade\nDifferentiation\nPatterns\n1\nWell differentiated\nLepidic-predominant with no or < 20% high-grade pattern\n2\nModerately differentiated\nAcinar or papillary-predominant with no or < 20% high-grade pattern\n3\nPoor differentiated\nAny tumour with \u2265 20% high-grade pattern (solid, micropapillary, cribriform, or complex\nglandular patterna)\naFused glands or single cells infiltrating in a desmoplastic stroma.", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724362", "page": 33, "cancer_type": "Unknown", "category": "Unknown", "cancer_site": "N0, N1", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 1382}}
{"chunk_id": "tnm_chunk_61", "text": "N0, N1\n\nInvasive Mucinous Adenocarcinoma\nA\nB\nFigure 5.\nA. \u0007CT showing diffuse bilateral airspace\nand ground-glass opacity with nodular\ncomponents.\nB. \u0007Macroscopic image shows a poorly\ndefined tumour with a soft mucoid\nappearance.\nC. \u0007Pie chart of molecular alterations in\ninvasive mucinous adenocarcinomas.\nD. \u0007Microscopically invasive mucinous\nadenocarcinoma shows columnar cells\nwith abundant apical intracytoplasmic\nmucin and small basally oriented\nnuclei with minimal cytological atypia\ngrowing.\nC\nD\nMinimally Invasive Adenocarcinoma\nA\nB\nFigure 4. A. CT scan showing part-solid nodule (circle) that is mostly ground-glass, with a small solid component measuring < 5\nmm B. Microscopically a lepidic-predominant tumour with a total size <30 mm and an invasive area of 4mm. The tumour mostly\nshows a lepidic pattern of growth (top and right), with  a nodule of invasive adenocarcinoma (bottom left).\nAdenocarcinoma In Situ\nFigure 3. A circumscribed proliferation of\nmalignant cells along the existing alveolar\nframework without invasive growth.\n2021 WHO Classification\nLung Adenocarcinoma in\nResected Specimens\nConquering Lung & Thoracic Cancers\nWorldwide in the 21st Century\nDiagnostic Features of Adenocarcinoma In Situ\n\u2022\t A small localized tumour (\u2264 30 mm)\n\u2022\t Pure lepidic growth\n\u2022\t No stromal, vascular, or pleural invasion\n\u2022\t No pattern of invasive adenocarcinoma (e.g. acinar, papillary, micropapillary,\nsolid, colloid, enteric, fetal, or invasive mucinous adenocarcinoma)\n\u2022\t No spread through airspaces\n\u2022\t Cell type mostly non-mucinous (type II pneumocytes or club cells) but very\nrarely may be mucinous (tall columnar cells with basal nuclei and abundant\ncytoplasmic mucin, sometimes resembling goblet cells)\n\u2022\t Nuclear atypia is inconspicuous\n\u2022\t Septal widening with sclerosis/elastosis is common, particularly in non-\nmucinous adenocarcinoma in situ.\n\n2021 WHO Classification\nMesothelioma\nConquering Lung & Thoracic Cancers\nWorldwide in the 21st Century\nMesothelioma in situ\nA preinvasive single-layer surface proliferation of neoplastic mesothelial cells.\n\u2022\t \u0007No thorascopic or imaging\nevidence of tumor\n\u2022\t \u0007History of recurrent pleural\neffusions\n\u2022\t \u0007Loss of BAP1 and/or MTAP\nby IHC and/or CDKN2A\nhomozygous deletion by FISH\nMesothelioma in situ\nBAP1 loss", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724366", "page": 33, "cancer_type": "Unknown", "category": "Unknown", "cancer_site": "N0, N1", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 2269}}
{"chunk_id": "tnm_chunk_62", "text": "Diffuse Mesothelioma\n\nDiffuse plural thickening by a malignant neoplasm with epithelioid, sarcomatoid, or biphasic histology\nDiffuse epithelioid mesothelioma:\n\u2022\t May appear cytologically bland\nor show marked atypia\n\u2022\t A variety of architectural\npatterns, cytologic and stromal\nfeatures may occur, some with\nprognostic significance\n\u2022\t Epithelioid mesothelioma\nshould also be graded\nTubulopapillary growth\nSolid growth\nDiffuse sarcomatoid mesothelioma:\n\u2022\t Characterized by spindle cells\narranged in fasicles or in\nhaphazard patterns.\n\u2022\t Desmoplastic mesothelioma is\ncharacterized by spindled cells\nwith minimal atypia arranged in\na patternless pattern in dense\nhyalinized stroma\nSarcomatoid mesothelioma\nDesmoplastic mesothelioma\nBiphasic mesothelioma with epitheli-\noid and sarcomatoid components\nTransitional morphology shows features\nin between epithelioid and sarcomatoid.\nReticulin stains (right) show fibers\nsurrounding each cell as opposed to\ngroups of cells as in epithelioid meso-\nthelioma, may be helpful in some cases.\nDiffuse biphasic mesothelioma:\n\u2022\t Composed of both epithelioid\nand sarcomatoid morphology;\n\u2022\t \u2265 10% of each component\nshould be present in resection\nspecimens.\n\u2022\t Areas of transitional\nmorphology should be\nconsidered sarcomatoid\n\n2021 WHO Classification", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724369", "page": 39, "cancer_type": "Unknown", "category": "Unknown", "cancer_site": "Diffuse Mesothelioma", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 1281}}
{"chunk_id": "tnm_chunk_63", "text": "Diffuse Pleural Mesothelioma\n\nConquering Lung & Thoracic Cancers\nWorldwide in the 21st Century", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724374", "page": 40, "cancer_type": "Unknown", "category": "Unknown", "cancer_site": "Diffuse Pleural Mesothelioma", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 94}}
{"chunk_id": "tnm_chunk_64", "text": "Histological Classification of Diffuse Pleural Mesothelioma\n\nType\nDescription\nPatterns/features\nFavorable\nUnfavorable\nReporting\nEpithelioid\nmesothelioma\nComposed of round\nepithelioid cells, usually\nwith cohesive architec-\nture, but single cells\nwithin a fibrous stroma\nmay also be seen\nArchitectural patterns:\nTubulopapillary\nTrabecular\nAdenomatoid\nSolid\nMicropapillary\nCytological features:\nRhabdoid\nDeciduoida\nSmall cella\nClear cella\nSignet ringa\nLymphohistiocytoid\nPleomorphic\nStromal features:\nMyxoid\nArchitectural patterns:\nTubulopapillary\nTrabecular\nAdenomatoid\nCytological features:\nLymphohistiocytoid\nLow nuclear gradea\nStromal features:\nMyxoid (if predominant,\ni.e. when \u2265 50% of\ntumor with < 50% solid\npattern contains myxoid\nstroma)\nArchitectural patterns:\nSolid (\u2265 50%)\nMicropapillary\nCytological features:\nRhabdoid\nPleomorphic\nLow nuclear gradeb\nNecrosis:\n(included in grading)\nGrade (high or\nlow), architec-\ntural patterns\npresent (and in\ndefinitive resec-\ntion specimens\nsuch as EPD\nand EPP,\npercentages of\neach pattern;\nfor all other\nspecimens,\nindicate \u201cwith\n... patterns/\nfeatures\u201d)\nSarcomatoid\nmesothelioma,\nincluding\ndesmoplastic\npattern\nComposed of elongated/\nspindle cells (> 2 times\nlonger than wide) ar-\nranged in solid sheets or\nwithin a fibrous stroma\nCytological features:\nLymphohistiocytoid\nTransitional\nPleomorphic\nStromal features:\nDesmoplastic\nWith heterologous dif-\nferentiation\nCytological features:\nLymphohistiocytoid\nCytological features:\nTransitional\nBiphasic\nmesothelioma\nShowing both epithelioid\nand sarcomatoid com-\nponents (in definitive\nresection specimens,\nnamely EPD and EPP, \u2265\n10% of each component\nis required for diagno-\nsis); for smaller samples,\nincluding biopsy and\ncytology specimens, the\ndiagnosis of biphasic\nmesothelioma can be\nrendered regardless of\npercentages of each\ncomponent present\nPercentage of\neach compo-\nnent should\nbe reported\nregardless of\nspecimen type", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724378", "page": 40, "cancer_type": "Unknown", "category": "Unknown", "cancer_site": "Histological Classification of Diffuse Pleural Mesothelioma", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 1919}}
{"chunk_id": "tnm_chunk_65", "text": "Grading of Epithelial Mesothelioma\n\nNuclear grade:\nNuclear atypia score:\t _____   1 for mild, 2 for moderate, 3 for severe\nMiotic count score:\n_____   1 for low (\u22641 mitosis/2mm2), 2 for intermediate (2-4 mitoses/2mm2),\n\n3 for high (\u2265 5 mitoses/2mm2)\nSum:\n_____   2 or 3 = nuclear grade I, 4 or 5 = nuclear grade II, 6 = nuclear grade III\nNecrosis: present/absent\nOverall tumor grade:\nLow grade = nuclear grades I and II without necrosis\nHigh grade = nuclear grades II with necrosis, nuclear grade III with or without necrosis\nReprinted with permission from WHO Classification of Tumours Editorial Board. Thoracic tumours. Lyon: IARC; 2021.\n\n2021 WHO Classification", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724382", "page": 40, "cancer_type": "Unknown", "category": "Unknown", "cancer_site": "Grading of Epithelial Mesothelioma", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 664}}
{"chunk_id": "tnm_chunk_66", "text": "Squamous Cell Carcinoma\n\n(SQCC)\nConquering Lung & Thoracic Cancers\nWorldwide in the 21st Century\nA malignant epithelial tumour characterized by the presence of keratinization,\nintercellular bridges, or immunohistochemical markers of squamous cell differentiation\nKeratinizing squamous cell\ncarcinoma with formation of\nkeratin pearls (left) and on cytology\nspecimen showing isolated\nmalignant cells with bizarrely\nshaped tadpole-appearance and\nkeratinized cytoplasm (right).\nKeratinization with pearl formation\nKeratinizing tumor cells (cytology)\nNon-keratinizing squamous\ncell carcinoma with tumor cells\ngrowing in solid pattern (left), no\nkeratinization and diffuse strongly\npositive nuclear p40 staining by\nimmunohistochemistry (right).\nCarcinoma with solid growth pattern\nP40 immunostain\nBasaloid squamous cell\ncarcinoma with cells showing\nscant cytoplasm, lobular growth\npattern and peripheral palisading\n(left), and diffuse p40 staining by\nimmunohistochemistry. Abrupt\nkeratinization and intercellular\nbridges may be seen (right).\nSolid carcinoma with lobular pattern\nIntercellular bridges\nSquamous dysplasia (left) and\ncarcinonoma in situ (right) are\npre-invasive lesions of squamous cell\ncarcinoma arising in the bronchial\nepithelium. They show a continuum\nof morphologically recognizable\nneoplastic histological changes\nassociated with accumulation of\nsomatic genetic alterations\nSevere dysplasia\nSquamous carcinoma in situ\nReprinted with permission from WHO Classification of Tumours Editorial Board. Thoracic tumours. Lyon: IARC; 2021.", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724386", "page": 41, "cancer_type": "Unknown", "category": "Unknown", "cancer_site": "Squamous Cell Carcinoma", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 1547}}
{"chunk_id": "tnm_chunk_67", "text": "Squamous Cell Carcinoma\n\nDiagnostic Criteria for Squamous Dysplasia and Squamous Carcinoma in Situ\nAbnormality Thickness\nCell Size\nMaturation/Orientation\nNuclei\nMild\ndysplasia\nMildly\nincreased\nMildly increased\nMild anisocytosis and\npleomorphism\nContinuous progression of maturation\nfrom base to luminal surface\nBasilar zone expanded, with cellular\ncrowding in the lower third of\nepithelium\nDistinct intermediate (prickle cell)\nzone present\nSuperficial flattening of epithelial cells\nMild variation of N:C ratio\nFinely granular chromatin\nMinimal angulation\nNucleoli inconspicuous or absent\nNuclei vertically oriented in lower third\nMitoses absent or very rare\nModerate\ndysplasia\nModerately\nincreased\nMildly increased\nCells often small\nMay have moderate\nanisocytosis and\npleomorphism\nPartial progression of maturation from\nbase to luminal surface\nBasilar zone expanded, with cellular\ncrowding in the lower two thirds of\nepithelium\nIntermediate zone confined to upper\nthird of epithelium\nSuperficial flattening of epithelial cells\nModerate variation of N:C ratio\nFinely granular chromatin\nAngulations, grooves, and lobulations\npresent\nNucleoli inconspicuous or absent\nNuclei vertically oriented in lower two thirds\nMitotic figures present in lower third\nSevere\ndysplasia\nMarkedly\nincreased\nMarkedly increased\nMay have marked\nanisocytosis and\npleomorphism\nLittle progression of maturation from\nbase to luminal surface\nBasilar zone expanded, with cellular\ncrowding well into the upper third of\nepithelium\nIntermediate zone greatly attenuated\nSuperficial flattening of epithelial cells\nN:C ratio often high and variable\nChromatin coarse and uneven\nNuclear angulations and folding prominent\nNucleoli frequently present and\nconspicuous\nNuclei vertically oriented in lower two thirds\nMitotic figures present in lower two thirds\nCarcinoma\nin situ\nMay or\nmay not be\nincreased\nMay be markedly\nincreased\nMay have marked\nanisocytosis and\npleomorphism\nNo progression of maturation from\nbase to luminal surface; epithelium\ncan be inverted, with little change in\nappearance\nBasilar zone expanded, with cellular\ncrowding throughout the epithelium\nIntermediate zone absent\nSurface flattening confined to the\nmost superficial cells\nN:C ratio often high and variable\nChromatin coarse and uneven\nNuclear angulations and folding prominent\nNucleoli may be present or inconspicuous\nNo consistent orientation of nuclei in\nrelation to epithelial surface\nMitotic figures present through full\nthickness\nSquamous Dysplasia and\nCarcinoma-In Situ\nConquering Lung & Thoracic Cancers\nWorldwide in the 21st Century\nSquamous cell carcinoma in situ.\nWhite-light reflective bronchoscopy (A) and\nautofluorescence bronchoscopy (B) of a squamous cell\ncarcinoma in situ with microinvasion in the trachea.\nThere was no light abnormality on the white-light\nreflectance bronchoscopy examination. A plaque-like\nlesion on white-light reflectance bronchoscopy (C) and\noptical coherence tomography (D) showing invasion of\nthe tumor through the basal membrane.", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724390", "page": 41, "cancer_type": "Unknown", "category": "Unknown", "cancer_site": "Squamous Cell Carcinoma", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 3012}}
{"chunk_id": "tnm_chunk_68", "text": "Squamous Cell Carcinoma\n\n2021 WHO Classification\nSmall Biopsy and\nCytology Samples\nConquering Lung & Thoracic Cancers\nWorldwide in the 21st Century\nGeneral Principles\n\u2022\t Minimize stains to maximize tissue for molecular testing\n\u2022\t Cut tissue block as sparingly as possible\n\u2022\t Obtain unstained slides for molecular at time of cutting block for IHC\n\u2022\t Use limited panel of IHC (i.e TTF-1 and P40): reduces NSCC-NOS\nfrom ~40% to <10%.\n\u2022\t Molecular testing, if clinically appropriate, can be performed on\nremaining tissue\nTravis WD, Brambilla E, Burke\nAP, Marx A, Nicholson AG. WHO\nClassification of Tumours of the\nLung, Pleura, Thymus and Heart.\nLyon: IARC; 2015.\u201d\nA. Adenocarcinoma (ADC) Cytology\nA. Squamous Cell Carcinoma (SQCC)\nCytology\nB. Nonsmall Cell Carcinoma (NSCC),\nFavor ADC\nB. NSCC, Favor SQCC", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724393", "page": 41, "cancer_type": "Unknown", "category": "Unknown", "cancer_site": "Squamous Cell Carcinoma", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 803}}
{"chunk_id": "tnm_chunk_69", "text": "C. P40\n\na) Cytology shows cluster of tumor\ncells around a small lumen with focal\nintracytoplasmic mucin, (b) NSCC, favor\nADC; solid but no glandular pattern,\n(c) TTF-1 is positive\na) Cytology shows pleomorphic and\nkeratinized tumor cells including a\ntadpole cell, (b) NSCC favor squamous\ncell carcinoma (c) P40 is positive (TTF-1\nwas negative)\nALK Rearranged\nAdenocarcinoma\nA) Cribriform Pattern", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724397", "page": 43, "cancer_type": "Unknown", "category": "Unknown", "cancer_site": "C. P40", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 395}}
{"chunk_id": "tnm_chunk_70", "text": "C) ALK FISH\n\nTerminology and Criteria for", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724400", "page": 43, "cancer_type": "Unknown", "category": "Unknown", "cancer_site": "C) ALK FISH", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 41}}
{"chunk_id": "tnm_chunk_71", "text": "Common Lung Cancers in\n\nSmall Biopsies and Cytology\nConquering Lung & Thoracic Cancers\nWorldwide in the 21st Century\nSmall Biopsy/Cytology\nTerminology\nMorphology/Stains\n2021 WHO Classification in\nResection Specimens\nAdenocarcinoma (describe\nidentifiable patterns present)\nMorphological adenocarcinoma\npatterns clearly present\nAdenocarcinoma (Predominant\npattern) Lepidic, Acinar, Papillary,\nSolid, Micropapillary\nAdenocarcinoma with lepidic pattern\n(if pure, add note: an invasive\ncomponent cannot be excluded)\nLepidic (nonmucinous)\nMinimally invasive adenocarcinoma,\nadenocarcinoma in situ or an invasive\nadenocarcinoma with a lepidic\ncomponent\nInvasive mucinous adenocarcinoma\n(describe patterns present; if pure\nlepidic pattern, use term mucinous\nadenocarcinoma with lepidic pattern\nAdenocarcinoma with colloid features\nAdenocarcinoma with fetal features\nAdenocarcinoma with enteric features\nInvasive mucinous adenocarcinoma\nColloid adenocarcinoma\nFetal adenocarcinoma\nEnteric adenocarcinoma\nNon-small cell carcinoma, favor\nadenocarcinoma\nMorphologic adenocarcinoma patterns\nnot present, but supported by special\nstains, i.e. +TTF-1\nAdenocarcinoma (solid pattern may\nbe just one component of the tumor)b\nSquamous cell carcinoma\nMorphologic squamous cell patterns\nclearly present\nSmall cell carcinoma\nNon-small cell carcinoma, favor\nsquamous cell carcinoma\nMorphologic squamous cell patterns\nnot present, but supported by stains\ni.e. +p40\nSquamous cell carcinoma,\n(nonkeratinizing pattern may be just\none component of the tumor)\nNon-small cell carcinoma, not\notherwise specified NSCC-NOS\nNo clear adenocarcinoma, squamous\nor neuroendocrine morphology or\nstaining pattern\nLarge cell carcinoma\nSmall cell carcinoma\nSmall cell carcinoma\nNon-small cell carcinoma with\nneuroendocrine (NE) morphology and\npositive NE markers, possible LCNEC\nLarge cell neuroendocrine carcinoma\n(LCNEC)\nMorphologic squamous cell and\nadenocarcinoma patterns present:\nNon-small cell carcinoma, NOS,\n(comment that adenocarcinoma\nand squamous components are\npresent and this could represent\nadenosquamous carcinoma).\nAdenosquamous carcinoma\nReprinted with permission from WHO Classification of Tumours Editorial Board. Thoracic tumours. Lyon: IARC; 2021.", "source_type": "tnm_table", "metadata": {"source_file": "Staging Cards 9th Edition 2024.pdf", "created_at": "2025-11-06T07:01:10.724403", "page": 44, "cancer_type": "Lung", "category": "Unknown", "cancer_site": "Common Lung Cancers in", "staging_component": null, "tnm_edition": "9th", "chunk_method": "semantic", "char_count": 2228}}
